PRL and migraine disorder: Dopamine agonists may therefore reduce migraine frequency and severity through two distinct mechanisms, one of which involves prolactin lowering and reduced trigeminal sensitization, and the other mediated by dopaminergic modulation of trigeminovascular signaling.